ETN
57
2
MCO
70
5
CF
41
-7
DVA
51
2
GE
77
5
MU
79
4
FIS
62
4
PVH
30
-2
FFIV
51
4
OXY
42
2
A
51
8
FITB
78
3
ROP
42
4
DOV
63
-6
GRMN
45
8
PG
43
-2
MCHP
58
11
SLG
37
6
ICE
60
3
TMO
62
2
ETN
57
2
MCO
70
5
CF
41
-7
DVA
51
2
GE
77
5
MU
79
4
FIS
62
4
PVH
30
-2
FFIV
51
4
OXY
42
2
A
51
8
FITB
78
3
ROP
42
4
DOV
63
-6
GRMN
45
8
PG
43
-2
MCHP
58
11
SLG
37
6
ICE
60
3
TMO
62
2
Financhill
Back

Defiance R2000 Target 30 Income ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
33

IWMY
Defiance R2000 Target 30 Income ETF

Last Price:
$20.35
Seasonality Move:
-15.14%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$38.36
Seasonality Move:
-16.78%
Sell
33
Defiance R2000 Target 30 Income ETF (IWMY) is a Sell

Is Defiance R2000 Target 30 Income ETF a Buy, Sell or Hold?

  • The current Defiance R2000 Target 30 Income ETF [IWMY] share price is $20.42. The Score for IWMY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • IWMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IWMY Stock Price Chart

What is Defiance R2000 Target 30 Income ETF's stock price today?

  • The Defiance R2000 Target 30 Income ETF share price today is $20.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IWMY is experiencing slight selling pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

IWMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 43.7 Sell
Chaikin Money Flow: -3145 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.29 - 20.65) Sell
Bollinger Bands (100): (20.96 - 23.24) Sell

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

IWMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.41 Buy
20-day SMA: 20.5 Sell
50-day SMA: 21.09 Sell
200-day SMA: 23.25 Sell
8-day EMA: 20.38 Buy
20-day EMA: 20.53 Sell
50-day EMA: 21.09 Sell
200-day EMA: 24.36 Sell

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

Defiance R2000 Target 30 Income ETF Earnings Growth & IWMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Defiance R2000 Target 30 Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):